Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26580 | 20171943 | Dig Liver Dis | Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. | 2010 | Details |
A26582 | 20168226 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2010 | Details |
A26583 | 20165979 | Dig Dis Sci | Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
A26584 | 20164781 | Eur J Gastroenterol Hepatol | The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. | 2010 | Details |
A26586 | 20158939 | Proc Nutr Soc | Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. | 2010 | Details |
A26591 | 20143458 | World J Gastroenterol | Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? | 2010 | Details |
A26592 | 20142825 | Int J Obes (Lond) | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. | 2010 | Details |
A26597 | 20128971 | Zhonghua Gan Zang Bing Za Zhi | [Metabolic characteristics of a fatty liver disease model induced by high-fat feeding in young rats]. | 2010 | Details |
A26603 | 20111022 | Obesity (Silver Spring) | Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. | 2010 | Details |
A26606 | 20101871 | Acta Clin Belg | Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics. | 2010 | Details |
A26608 | 20101463 | Dig Dis Sci | Nonalcoholic fatty liver disease: a review and update. | 2010 | Details |
A26609 | 20096896 | Metabolism | Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. | 2010 | Details |
A26611 | 20095887 | Scand J Gastroenterol | Serum chemerin and vaspin in non-alcoholic fatty liver disease. | 2010 | Details |
A26612 | 20093562 | Am J Physiol Gastrointest Liver Physiol | The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. | 2010 | Details |
A26613 | 20093511 | Radiology | Presence of coronary plaques in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26615 | 20088867 | Liver Int | The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. | 2010 | Details |
A26617 | 20087305 | J Sports Med Phys Fitness | Aerobic exercise and non-alcoholic fatty liver disease: a case report. | 2009 | Details |
A26618 | 20085121 | Eur Rev Med Pharmacol Sci | Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. | 2010 | Details |
A26620 | 20082871 | Arch Med Res | High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
A26624 | 20079327 | Zhonghua Nei Ke Za Zhi | [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.]. | 2009 | Details |
A26625 | 20078219 | Annu Rev Pathol | Nonalcoholic fatty liver disease: pathology and pathogenesis. | 2010 | Details |
A26627 | 20074156 | J Gastroenterol Hepatol | Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. | 2010 | Details |
A26628 | 20066503 | Obes Surg | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. | 2010 | Details |
A26631 | 20059344 | Annu Rev Med | Emerging molecular targets for the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
A26635 | 20045153 | Metabolism | Plasma apelin levels in subjects with nonalcoholic fatty liver disease. | 2009 | Details |
A26637 | 20043126 | Int J Mol Med | Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats. | 2010 | Details |
A26638 | 20042103 | Lipids Health Dis | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | 2009 | Details |
A26642 | 24149634 | J Sports Sci Med | Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. | 2010 | Details |
A26650 | 21442055 | Hepatol Int | Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. | 2010 | Details |
A26651 | 21387764 | Przegl Lek | [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers]. | 2010 | Details |
A26652 | 20041406 | Hepatology | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | 2010 | Details |
A26656 | 20038265 | Immunopharmacol Immunotoxicol | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. | 2010 | Details |
A26659 | 20033348 | Obes Surg | SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. | 2009 | Details |
A26667 | 20022856 | Adv Med Sci | Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. | 2009 | Details |
A26669 | 20022466 | Nutrition | Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. | 2009 | Details |
A26677 | 20001571 | Gynecol Endocrinol | Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role? | 2010 | Details |
A26679 | 19961393 | Clin Chem Lab Med | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. | 2010 | Details |
A26680 | 19961041 | Eur Rev Med Pharmacol Sci | Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. | 2010 | Details |
A26682 | 19958640 | Zhonghua Gan Zang Bing Za Zhi | [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease]. | 2009 | Details |
A26684 | 19957147 | Methods Mol Biol | Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? | 2010 | Details |
A26686 | 19956652 | PLoS One | Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice. | 2009 | Details |
A26689 | 19948145 | Curr Biol | An emerging role of mTOR in lipid biosynthesis. | 2009 | Details |
A26691 | 19946731 | J Gastroenterol | Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. | 2009 | Details |
A26693 | 19945407 | Cell Metab | Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. | 2009 | Details |
A26694 | 19942238 | Metabolism | Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. | 2009 | Details |
A26704 | 19929783 | Curr Med Chem | Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. | 2009 | Details |
A26705 | 19926158 | Diabetes Res Clin Pract | Abnormal aortic elasticity in patients with liver steatosis. | 2009 | Details |
A26708 | 19923096 | Orv Hetil | [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease]. | 2009 | Details |
A26709 | 19921118 | Adv Ther | Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status. | 2009 | Details |
A26710 | 19919948 | Gut | Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease. | 2009 | Details |
A26714 | 19913842 | Metabolism | Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat. | 2009 | Details |
A26717 | 19910932 | Am J Hypertens | Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. | 2009 | Details |
A26720 | 19900166 | Clin Sci (Lond) | Hypoxia and non-alcoholic fatty liver disease. | 2009 | Details |
A26722 | 19897197 | Atherosclerosis | Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. | 2009 | Details |
A26724 | 19892897 | Postgrad Med J | The metabolic syndrome: common origins of a multifactorial disorder. | 2009 | Details |
A26725 | 19891587 | Scand J Gastroenterol | Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis. | 2009 | Details |
A26726 | 19891019 | World J Gastroenterol | Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis. | 2009 | Details |
A26727 | 19890679 | Hepatol Int | Serum α-fetoprotein levels in liver steatosis. | 2009 | Details |
A26728 | 19887498 | Hum Reprod | Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. | 2009 | Details |
A26734 | 19880582 | Diabetes Care | Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis. | 2009 | Details |
A26737 | 19875987 | Obesity (Silver Spring) | Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. | 2009 | Details |
A26738 | 21160968 | World J Hepatol | Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. | 2009 | Details |
A26740 | 19861959 | Am J Gastroenterol | Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. | 2009 | Details |
A26741 | 19860210 | Rinsho Byori | [Diagnosis and therapy in NASH]. | 2009 | Details |
A26746 | 19845871 | Obes Rev | Non-alcoholic fatty liver disease from pathogenesis to management: an update. | 2009 | Details |
A26747 | 19840251 | Liver Int | Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. | 2009 | Details |
A26750 | 19834957 | Cancer | Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. | 2009 | Details |
A26753 | 19832698 | Clin Sci (Lond) | Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. | 2009 | Details |
A26756 | 19799688 | J Gastroenterol Hepatol | The liver and the waistline: Fifty years of growth. | 2009 | Details |
A26759 | 19820404 | Eur J Gastroenterol Hepatol | Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? | 2010 | Details |
A26768 | 19818304 | Clin Liver Dis | Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. | 2009 | Details |
A26774 | 19813185 | Muscle Nerve | Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy. | 2010 | Details |
A26775 | 19811343 | Scand J Gastroenterol | Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. | 2009 | Details |
A26776 | 19809879 | Rev Endocr Metab Disord | Identification and treatment of metabolic complications in pediatric obesity. | 2009 | Details |
A26784 | 19788607 | J Gastroenterol Hepatol | Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. | 2009 | Details |
A26789 | 19781663 | Biochim Biophys Acta | n-3 PUFA and lipotoxicity. | 2009 | Details |
A26791 | 19779336 | Curr Opin Lipidol | Thiazolidinediones and the liver in humans. | 2009 | Details |
A26793 | 19777393 | Curr Opin Investig Drugs | Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. | 2009 | Details |
A26794 | 19773396 | J Clin Endocrinol Metab | Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. | 2009 | Details |
A26798 | 19765850 | J Hepatol | Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. | 2009 | Details |
A26800 | 19761871 | Contemp Clin Trials | Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. | 2009 | Details |
A26804 | 19751410 | Ann N Y Acad Sci | From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis. | 2009 | Details |
A26809 | 19740705 | Clin Immunol | The role of resistin as a regulator of inflammation: Implications for various human pathologies. | 2009 | Details |
A26812 | 19733470 | J Nutr Biochem | Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis. | 2009 | Details |
A26813 | 19731869 | Vnitr Lek | [Metabolic syndrome and the liver (NAFLD/NASH)]. | 2009 | Details |
A26814 | 19731235 | Hepatology | Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. | 2009 | Details |
A26815 | 19730384 | Eur J Gastroenterol Hepatol | Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. | 2010 | Details |
A26816 | 19728847 | Clin Chem Lab Med | A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients. | 2009 | Details |
A26818 | 19727004 | J Clin Gastroenterol | Effect of weight loss on nonalcoholic fatty liver disease. | 2010 | Details |
A26820 | 19724016 | Am J Physiol Endocrinol Metab | Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. | 2009 | Details |
A26821 | 19720629 | J Clin Pathol | Werner syndrome as a possible cause of non-alcoholic steatohepatitis. | 2009 | Details |
A26826 | 19702910 | J Gastroenterol Hepatol | Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. | 2009 | Details |
A26828 | 19702660 | J Med Primatol | Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers. | 2009 | Details |
A26829 | 19697129 | Dig Dis Sci | Clinical and histological features of nonalcoholic fatty liver disease in children. | 2009 | Details |
A26830 | 19693638 | Obes Surg | Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. | 2009 | Details |
A26831 | 19691668 | Aliment Pharmacol Ther | Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A26832 | 19690397 | Gerontology | Non-alcoholic fatty liver disease in older people. | 2009 | Details |
A26841 | 19671519 | Hormones (Athens) | In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. | 2009 | Details |
A26844 | 19667999 | Eur J Gastroenterol Hepatol | Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. | 2010 | Details |
A26848 | 19664840 | J Hepatol | Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. | 2009 | Details |